DELTEC ASSET MANAGEMENT LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 149 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2016. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
DELTEC ASSET MANAGEMENT LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2016$65,000
+3.2%
11,5000.0%0.02%
-6.2%
Q2 2016$63,000
-25.9%
11,5000.0%0.02%
-23.8%
Q1 2016$85,000
+66.7%
11,500
+15.0%
0.02%
+90.9%
Q4 2014$51,00010,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2016
NameSharesValueWeighting ↓
Third Security, LLC 17,815,708$47,033,0002.93%
Essex Woodlands Management, Inc. 2,764,908$7,130,0002.60%
Belmont Global Advisors, Inc. 973,000$2,569,0002.01%
Belmont Global Advisors, Inc. 135,700$358,0000.28%
MSD Partners, L.P. 2,750,000$7,260,0000.22%
SFMG, LLC 99,850$264,0000.08%
Rotella Capital Management, Inc. 11,090$29,0000.03%
WESTPORT RESOURCES MANAGEMENT INC 33,500$88,0000.02%
SMITH ASSET MANAGEMENT GROUP LP 236,590$625,0000.02%
FRANKLIN STREET ADVISORS INC /NC 41,150$109,0000.02%
View complete list of ZIOPHARM ONCOLOGY INC shareholders